BIOMAT Database Logo BIOMAT Database Logo

Retinal ganglion cell dendritic atrophy in DBA/2J glaucoma. 2013

Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom.

Glaucoma is a complex disease affecting an estimated 70 million people worldwide, characterised by the progressive degeneration of retinal ganglion cells and accompanying visual field loss. The common site of damage to retinal ganglion cells is thought to be at the optic nerve head, however evidence from other optic neuropathies and neurodegenerative disorders suggests that dendritic structures undergo a prolonged period of atrophy that may accompany or even precede soma loss and neuronal cell death. Using the DBA/2J mouse model of glaucoma this investigation aims to elucidate the impact of increasing intraocular pressure on retinal ganglion cell dendrites using DBA/2J mice that express YFP throughout the retinal ganglion cells driven by Thy1 (DBA/2J.Thy1(YFP)) and DiOlistically labelled retinal ganglion cells in DBA/2J mice. Here we show retinal ganglion cell dendritic degeneration in DiOlistically labelled DBA/2J retinal ganglion cells but not in the DBA/2J.Thy1(YFP) retinal ganglion cells suggesting that a potential downregulation of Thy1 allows only 'healthy' retinal ganglion cells to express YFP. These data may highlight alternative pathways to retinal ganglion cell loss in DBA/2J glaucoma.

UI MeSH Term Description Entries
D007429 Intraocular Pressure The pressure of the fluids in the eye. Ocular Tension,Intraocular Pressures,Ocular Tensions,Pressure, Intraocular,Pressures, Intraocular,Tension, Ocular,Tensions, Ocular
D008164 Luminescent Proteins Proteins which are involved in the phenomenon of light emission in living systems. Included are the "enzymatic" and "non-enzymatic" types of system with or without the presence of oxygen or co-factors. Bioluminescent Protein,Bioluminescent Proteins,Luminescent Protein,Photoprotein,Photoproteins,Protein, Bioluminescent,Protein, Luminescent,Proteins, Bioluminescent,Proteins, Luminescent
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D009901 Optic Nerve Diseases Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect. Cranial Nerve II Diseases,Foster-Kennedy Syndrome,Optic Disc Disorders,Optic Disk Disorders,Optic Neuropathy,Second Cranial Nerve Diseases,Cranial Nerve II Disorder,Neural-Optical Lesion,Disc Disorder, Optic,Disk Disorder, Optic,Disorder, Optic Disc,Foster Kennedy Syndrome,Lesion, Neural-Optical,Neural Optical Lesion,Neural-Optical Lesions,Neuropathy, Optic,Optic Disc Disorder,Optic Disk Disorder,Optic Nerve Disease,Optic Neuropathies,Syndrome, Foster-Kennedy
D003712 Dendrites Extensions of the nerve cell body. They are short and branched and receive stimuli from other NEURONS. Dendrite
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D005901 Glaucoma An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) Glaucomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
March 2007, Investigative ophthalmology & visual science,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Microtubule Imaging Reveals Cytoskeletal Deficit Predisposing the Retinal Ganglion Cell Axons to Atrophy in DBA/2J.
November 2018, Investigative ophthalmology & visual science,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice.
October 2007, Investigative ophthalmology & visual science,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2J mouse model of glaucoma.
October 2007, Investigative ophthalmology & visual science,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma.
December 2007, The Journal of cell biology,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Melanopsin-expressing retinal ganglion cell loss and behavioral analysis in the Thy1-CFP-DBA/2J mouse model of glaucoma.
August 2013, Science China. Life sciences,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma.
December 2016, The Journal of comparative neurology,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
May 1998, Investigative ophthalmology & visual science,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice.
October 2005, The Journal of cell biology,
Pete A Williams, and Gareth R Howell, and Jessica M Barbay, and Catherine E Braine, and Gregory L Sousa, and Simon W M John, and James E Morgan
Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model.
September 2002, Vision research,
Copied contents to your clipboard!